Large gap with delayed quotes
|
Last quote
01/17/2025 -
16:11:06
|
Bid
01/17/2025 -
16:11:06
|
Bid Volume |
Ask
01/17/2025 -
16:11:07
|
Ask Volume |
|---|---|---|---|---|
|
89.68
-0.91
(
-1.00% )
|
89.68
|
1,536 |
89.70
|
1,100 |
Analysis date: 14.01.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.09.2024.
Interest
Strong
Strong
Strong interest since 07.01.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 29.10.2024 at a price of 95.74.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, at its current price the stock is strongly undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 29.10.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is
4wk Rel Perf
3.86%
3.86%
The four week relative overperformance versus STOXX600 is 3.86%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 15.03.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.62%.
Mkt Cap in $bn
196.10
196.10
With a market capitalization >$8bn, NOVARTIS AG is considered a large-cap stock.
G/PE Ratio
1.10
1.10
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
11.54
11.54
The estimated PE is for the year 2026.
LT Growth
8.66%
8.66%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
21
21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
3.99%
3.99%
The twelve month estimated dividend yield represents 46.05% of earnings forecasts.
Beta
81
81
For 1% of index variation, the stock varies on average by 0.81%.
Correlation
0.52
0.52
51.84% of stock movements are explained by index variations.
Value at Risk
10.82
10.82
The value at risk is estimated at CHF 10.82. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002